
      Isotype
    

      Formulation Description
    
Supplied as a 0.2 μm filtered solution of PBS, pH7.4.

      Purity-SDS-PAGE
    
    Greater than 95% as determined by reducing SDS-PAGE.(QC verified)
 Greater than 95% as determined by reducing SDS-PAGE.(QC verified) 
      Storage
    
24 months from manufacturing at ≤-20 °C; 1 month, 2 to 8 °C under sterile conditions.

      Shipping
    
The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.

      Background
    
Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation.
For Research or Manufacturing Use Only, Not for Use in Diagnostic or Therapeutic Procedures.
Novoprotein is a trademark of Novoprotein Scientific Inc. visit our trademark information page: 
TradeMark.
All other trademarks are the property of their respective owners.